Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,389,000 | 5,636,000 | 5,714,000 | 5,414,000 | 5,846,000 |
| Marketable Securities | 204,000 | 203,000 | 184,000 | 170,000 | 166,000 |
| Inventories | 3,959,000 | 4,008,000 | 3,873,000 | 4,035,000 | 4,271,000 |
| Other current assets | 5,712,000 | 6,431,000 | 6,055,000 | 6,774,000 | 6,026,000 |
| TOTAL | $17,264,000 | $16,278,000 | $16,167,000 | $16,393,000 | $16,309,000 |
| Non-Current Assets | |||||
| PPE Net | 8,663,000 | 8,616,000 | 8,748,000 | 8,747,000 | 9,019,000 |
| Intangibles | 11,396,000 | 11,264,000 | 11,556,000 | 11,592,000 | 12,249,000 |
| Other Non-Current Assets | 5,134,000 | 4,644,000 | 4,609,000 | 4,678,000 | 4,501,000 |
| TOTAL | $25,193,000 | $24,524,000 | $24,913,000 | $25,017,000 | $25,769,000 |
| Total Assets | $42,457,000 | $40,802,000 | $41,080,000 | $41,410,000 | $42,078,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,698,000 | 872,000 | 1,039,000 |
| Accounts payable and accrued liabilities | 7,160,000 | 7,058,000 | 2,568,000 | 7,174,000 | 7,268,000 |
| TOTAL | $15,402,000 | $14,533,000 | $15,010,000 | $13,106,000 | $13,621,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 12,203,000 | 14,209,000 | 14,229,000 |
| Other Non-Current Liabilities | 17,691,000 | 15,069,000 | 3,423,000 | 4,286,000 | 3,320,000 |
| TOTAL | $19,259,000 | $16,693,000 | $17,243,000 | $20,073,000 | $19,022,000 |
| Total Liabilities | $34,661,000 | $31,226,000 | $32,253,000 | $33,179,000 | $32,643,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,367,000 | 1,390,000 | 1,387,000 | 1,392,000 | 1,400,000 |
| Retained earnings | 2,051,000 | 3,956,000 | 3,370,000 | 3,147,000 | 4,505,000 |
| Other shareholders' equity | 1,757,000 | 1,648,000 | 1,602,000 | 1,352,000 | 1,272,000 |
| TOTAL | $7,052,000 | $8,776,000 | $8,032,000 | $7,443,000 | $8,681,000 |
| Total Liabilities And Equity | $41,713,000 | $40,002,000 | $40,285,000 | $40,622,000 | $41,324,000 |